To nullify modifications made by the Food and Drug Administration on January 3, 2023, to the risk evaluation and mitigation strategy under section 505-1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1) for mifepristone, and for other purposes.

UnPac.us is a revolutionary crowdfunding platform where your contributions speak louder than ever. Support or oppose specific congressional bills, and lawmakers only receive funds if they vote your way. This ensures your voice is directly influencing policy decisions. Join us in transforming the political landscape for a more transparent and participatory democracy.